Oncoendocrinology SIG

March 10, 2023

Gain cutting-edge knowledge on the latest advances in cancer care to understand the impact on the endocrine system and long-term treatment options for survivors. The Oncoendocrinology SIG looks to increase interest in a niche area of practice and encourage collaboration in clinical care and research development.

Topics we will be reviewing include:

  • Developing academic oncoendocrinology clinical, educational and research programs;
  • Managing incident endocrine conditions in children and adults with cancer;
  • Diagnosing and treating endocrine-related adverse events from immune, hormonal and targeted cancer therapies;
  • Managing the long-term endocrine aspects of childhood and adult cancer survivors;
  • Understanding the mechanisms through which cancer and its treatments are linked to endocrine and metabolic conditions.

Engage with your peers in the SIG subgroup in the EndoForum online community in DocMatter. View the Oncoendocrinology SIG leadership roster.

Oncoendocrinology SIG Past Webinars

Collaborative webinar presented by Oncoendocrinology SIG and Transgender Research & Medicine SIG  

Date: January 4, 2024 
Time: 12:00 to 1:30 PM ET 

Moderator: Ole-Petter R. Hamnvik, MB, BCh, BAO 
Case Presenters: Tugce Akcan, MD; and Ling Zhu, MB, BChir   
Expert Discussants: Ann Partridge, MD, MPH; Alexi Wright, MD, MPH; and Koen M. A. Dreijerink, MD, PhD

Description: As increasing numbers of transgender and gender diverse patients are seeking gender-affirming hormone treatment, more patients are needing to balance the risks and benefits of such treatment in the setting of known or newly diagnosed sex hormone-sensitive cancers (for example breast cancer and cancers of the reproductive tract). In this webinar, experts in oncology and gender-affirming care are discussing two clinical cases, providing their insights in the considerations that need to be made. 

Learning Objectives: 

  1. Appraise current data on cancer risk with gender-affirming hormone therapy.
  2. Summarize therapeutic approaches for gender affirmation in transgender patients who are diagnosed with sex-hormone sensitive cancers.
  3. Contrast post-cancer diagnosis sex hormone management in cisgender people from management in transgender and gender diverse people.

The Metabolic Effects of Novel Cancer Therapies

April 24, 2023

Emily Gallagher 
Associate Professor 
Icahn Mount Sinai Hospital 

Marcus DaSilva Goncalves, MD, PhD
Assistant Professor of Medicine 
Weill Cornell Medicine in New York 

Yee-Ming Melody Cheung, MBBS, PhD 
Austin Health 
Brigham and Women’s Hospital 

Learning Objectives:

  • Describe novel small molecular inhibitors being used to treat a variety of cancers
  • Understand how these treatments can lead to systemic metabolic effects
  • Explain how dietary interventions may benefit individuals with cancer on targeted therapies

View Recording

The Oncoendocrinology SIG held its inaugural webinar, Introduction to Oncoendocrinology, on September 27, 2022. Oncoendocrinology addresses the endocrine needs of cancer patients. Learn more about this emerging field and how it can be incorporated in your clinical practice.

Learning Objectives:

  1. Describe the field of oncoendocrinology and the unique considerations relating to the clinical care of oncoendocrine patients
  2. Review the infrastructure and model of care of an established oncoendocrine clinic.
  3. Determine the obstacles and challenges associated with establishing an oncoendocrine clinic.

View Recording

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.